RWC 340B Logo hi res


July 9, 2021:  RWC-340B, a national association of Ryan White HIV clinics, enthusiastically supports introduction of the PROTECT Act by Representatives McKinley (R-WV) and Spanberger (D-VA), longtime and stalwart champions of the 340B Drug Pricing Program.

This bipartisan bill seeks to prevent pharmacy benefit managers (PBMs) and other third-party payers from paying below-market rates or engaging in other discriminatory contracting practices that undermine participation in the 340B Program by Ryan White clinics, federally qualified health centers and other safety net providers.

By singling out 340B pharmacies for reduced reimbursement, for-profit PBMs usurp the benefit of the 340B Program from safety net providers which both limits the providers’ ability to care for vulnerable patients and increases pressure on taxpayers to make up the difference. Other discriminatory practices prohibited by the bill include imposition of increased pharmacy fees, exclusion from PBM networks, interference with patient choice, and application of onerous claims reporting requirements.

“RWC-340B has been fighting against these unfair and abusive practices for the last five years. Most recently, we took our fight to the states where dozens of state legislatures enacted laws or are contemplating doing so to stop PBMs from exploiting the 340B Program,” said Shannon Stephenson, CPA, MBA, CEO of Cempa Community Care in Tennessee, and President of Ryan White Clinics for 340B Access (RWC-340B). Stephenson elaborated, “”These practices are a direct attack on safety net providers serving our country’s most vulnerable patients and must stop.”

“Now, with the leadership of Representatives McKinley and Spanberger, safety net providers are taking this fight to Congress to preserve and protect our right to use 340B savings, which allow us to treat more vulnerable patient populations or improve services, rather than allowing for-profit middlemen to line their pockets at our expense,” she said.

Another key component of the McKinley-Spanberger legislation is the requirement that HHS contract with a neutral, third-party to serve as a claims data clearinghouse to protect drug manufacturers from giving Medicaid rebates and 340B discounts on the same drugs. The contractor will collect data on 340B drugs reimbursed by Medicaid to ensure that those claims are not included in States’ Medicaid rebate requests. Stephenson said, “It’s the right thing to do. Federal government oversight is necessary to ensure that manufacturers providing 340B discounts on drugs are not also paying state rebates on those drugs.”


RWC-340B is a national association of HIV/AIDS health care clinics and service providers that receive funding under the Ryan White CARE Act and participate as covered entities in the 340B program. Ryan White clinics are dedicated to caring for low-income and vulnerable patients living with HIV/AIDS. Many of the association’s Ryan White members are also Federally Qualified Health Centers (FQHCs), FQHC “look-alikes”, sexually transmitted disease clinics, and safety net hospitals. See RWC-340B’s website.